Cox, David A <br/><br/>
Proteomic systems evaluation of the molecular validity of preclinical psychosis models compared to schizophrenia brain pathology.  [electronic resource] 

 -  Schizophrenia research  11 2016 
 - 98-107 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1573-2509 
<br/><br/><label>Standard No.: </label>10.1016/j.schres.2016.06.012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Chromatography, Liquid<br/>Disease Models, Animal<br/>Humans<br/>Ketamine<br/>Machine Learning<br/>Male<br/>Mice, Transgenic<br/>Phencyclidine<br/>Prefrontal Cortex--metabolism<br/>Protein Interaction Maps<br/>Proteomics<br/>Psychotic Disorders--metabolism<br/>Rats<br/>Receptors, N-Methyl-D-Aspartate--deficiency<br/>Schizophrenia--metabolism<br/>Tandem Mass Spectrometry